Real-time enrollment status for this newly diagnosed mgmt unmethylated glioblastoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:54 PM UTC
| NCT Number | NCT05734560 |
| Recruiting Status | Recruiting |
| Condition | Newly Diagnosed MGMT Unmethylated Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Darell Bigner |
| Last Updated on CT.gov | October 6, 2025 (Oct 6, 2025) |
As of July 18, 2026: Clinical trial NCT05734560 is currently recruiting participants. This phase1 study for newly diagnosed mgmt unmethylated glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Darell Bigner. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05734560 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05734560 was last updated Oct 6, 2025 (October 6, 2025). HelloStudys verifies this status automatically.